Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-029241)

Filing Details

Accession Number:: 0001209191-13-029241
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-05-28 19:42:45
Reporting Period:: 2013-05-13

Filing Date:: 2013-05-28
Accepted Time:: 2013-05-28 19:42:45
Original Submission Date:: 2013-05-15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356857	Trius Therapeutics Inc	TSRX	Pharmaceutical Preparations (2834)	201320630

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1479790	Philippe Prokocimer	C/O Trius Therapeutics, Inc. 6310 Nancy Ridge Dr, # 105 San Diego CA 92121	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-05-13	12,000	$7.65	98,022	No	4	S	Indirect	By The Philippe Prokocimer and Maria Prokocimer Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By The Philippe Prokocimer and Maria Prokocimer Family Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,429	Direct

Footnotes

The reporting person filed a Form 4 reporting a sale of 12,000 shares of common stock on May 13, 2013 which was cancelled by the broker. As ofMay 13, 2013, the reporting person owned 98,022 shares of common stock indirectly by trust.
Includes 396 and 534 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/18/12 and 11/20/12, respectively.